Matrix Private Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Matrix Private Capital Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,349	Closed	-$241K	–	195
2022 Q4	$241K	Sell	3,349 -62	-2%	-$4.67K	0.16%	113
2022 Q3	$242K	Sell	3,411 -3	-0.1%	-$218	0.16%	106
2022 Q2	$265K	Buy	3,414 +3	+0.1%	+$228	0.15%	121
2022 Q1	$251K	Buy	3,411 +2	+0.1%	+$134	0.12%	148
2021 Q4	$213K	Buy	+3,409	New	+$200K	0.1%	174
2021 Q3	–	Sell	-3,080	Closed	-$206K	–	245
2021 Q2	$206K	Buy	+3,080	New	+$201K	0.11%	167
2020 Q4	–	Sell	-4,291	Closed	-$259K	–	221
2020 Q3	$259K	Hold	4,291	–	–	0.26%	95
2020 Q2	$252K	Sell	4,291 -78	-2%	-$4.67K	0.28%	101
2020 Q1	$244K	Sell	4,369 -1,469	-25%	-$89.8K	0.35%	87
2019 Q4	$375K	Buy	+5,838	New	+$334K	0.39%	81

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Matrix Private Capital Group's BMY Position: Q1 2023 in Review

Matrix Private Capital Group sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 3,349 shares — an estimated $241K sold.

Matrix Private Capital Group first reported a position in BMY in Q4 2019 and held it in 10 quarters. The position peaked at $375K in Q4 2019. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Matrix Private Capital Group reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Matrix Private Capital Group sold 3,349 Bristol-Myers Squibb shares in Q1 2023, an estimated $241K.
Matrix Private Capital Group first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 10 quarters.
Matrix Private Capital Group's Bristol-Myers Squibb position peaked at $375K in Q4 2019.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Matrix Private Capital Group's 13F filing for Q1 2023, filed 15 May 2023.